GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Coreline Soft Co Ltd (XKRX:384470) » Definitions » Debt-to-Equity

Coreline Soft Co (XKRX:384470) Debt-to-Equity : 0.06 (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Coreline Soft Co Debt-to-Equity?

Coreline Soft Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩670 Mil. Coreline Soft Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩0 Mil. Coreline Soft Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₩10,613 Mil. Coreline Soft Co's debt to equity for the quarter that ended in Mar. 2024 was 0.06.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Coreline Soft Co's Debt-to-Equity or its related term are showing as below:

XKRX:384470' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.06   Med: 0.15   Max: 0.59
Current: 0.06

During the past 3 years, the highest Debt-to-Equity Ratio of Coreline Soft Co was 0.59. The lowest was 0.06. And the median was 0.15.

XKRX:384470's Debt-to-Equity is ranked better than
80.93% of 194 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.23 vs XKRX:384470: 0.06

Coreline Soft Co Debt-to-Equity Historical Data

The historical data trend for Coreline Soft Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coreline Soft Co Debt-to-Equity Chart

Coreline Soft Co Annual Data
Trend Dec20 Dec21 Dec22
Debt-to-Equity
0.24 0.12 0.59

Coreline Soft Co Quarterly Data
Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Debt-to-Equity Get a 7-Day Free Trial 0.59 N/A 0.14 0.16 0.06

Competitive Comparison of Coreline Soft Co's Debt-to-Equity

For the Diagnostics & Research subindustry, Coreline Soft Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coreline Soft Co's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Coreline Soft Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Coreline Soft Co's Debt-to-Equity falls into.



Coreline Soft Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Coreline Soft Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Coreline Soft Co's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Coreline Soft Co  (XKRX:384470) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Coreline Soft Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Coreline Soft Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Coreline Soft Co (XKRX:384470) Business Description

Traded in Other Exchanges
N/A
Address
49, Worldcupbuk-ro 6-gil, Mapo-gu, 4th and 5th floors, Yeonnam-dong, Seoul, KOR
Coreline Soft Co Ltd is an Artificial Intelligence-based 3D medical image analysis solution company. Their core technology is XAI (Explainable AI) technology, which assists diagnosis by fully automatically and accurately quantitatively analyzing 3D medical images and providing results and supporting data to medical staff. The company's main product is a solution used to assist medical staff in diagnosis or support treatment and research by analyzing CT (Computerized Tomography) images of the chest, head and neck, etc.

Coreline Soft Co (XKRX:384470) Headlines

No Headlines